Incyte | INCY - Ebit

股票价格
98.84
每天变化
-0.26 -0.26%
每月一次
5.01%
每年
59.34%
Q2 预测
92.62


金融业
股票价格
USD
资产
USD 7.34B
现金及等价物
USD 4.02B
销售成本
USD 121.18M
流动资产
USD 5.48B
流动负债
USD 1.49B
债务
USD 40.41M
EBIT
USD 383.88M
EBITDA
USD 414.51M
员工
2.62K
EPS每股收益
USD 1.81
股本和储备
USD 5.62B
销售毛利
USD 1.17B
债务利息支出
USD 569K
利息收入
USD 30.75M
贷款资金
USD 29.41M
市值
USD 22.13B
净收入
USD 299.28M
营业费用
USD 5.62B
营业利润
USD 383.88M
普通股股本
USD 199.95M
PE价格收益
15.35
税前利润
USD 389.94M
销售收入
USD 1.27B
销售和管理费用
USD 390.41M
股票
USD 115.62M
贸易债权人
USD 228.62M
应收帐款人
USD 1.05B


Ebit 更改 日
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agenus USD 14.4M 19.26M 2025-12
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Biogen USD 514.3M 502.8M 2026-03
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -118M 97M 2026-03
MacroGenics USD -12.1M 32.26M 2025-12
Merck USD 6.24B 1.32B 2025-12
Moderna USD -857M 597M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Neurocrine Biosciences USD 227.9M 11.4M 2025-12
Novartis USD 4.06B 530M 2025-12
Novartis USD 4.06B 413M 2025-12
Pfizer USD 4.65B 71M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12